The endoplasmic reticulum (ER) is an interconnected network of tubular and planar membranes that supports the synthesis and export of proteins, carbohydrates and lipids. Phospholipids, in particular phosphatidylcholine (PC), are synthesized in the ER where they have essential functions including provision of membranes required for protein synthesis and export, cholesterol homeostasis, and triacylglycerol storage and secretion. Coordination of these biological processes is essential, as highlighted by findings that link phospholipid metabolism in the ER with perturbations in lipid storage/secretion and stress responses, ultimately contributing to obesity/diabetes, atherosclerosis and neurological disorders. Phospholipid synthesis is not uniformly distributed in the ER but is localized at membrane interfaces or contact zones with other organelles, and in dynamic, proliferating ER membranes. The topology of phospholipid synthesis is an important consideration when establishing the etiology of diseases that arise from ER dysfunction. This review will highlight our current understanding of the contribution of phospholipid synthesis to proper ER function, and how alterations contribute to aberrant stress responses and disease. This article is part of a Special Issue entitled: Functional and structural diversity of endoplasmic reticulum.
Introduction
The endoplasmic reticulum (ER) is the primary site for phospholipid synthesis and also accounts for >60% of phospholipid mass in a variety of cell types. At the same time, the phospholipid content and composition of the ER are in constant flux owing to constitutive and regulated export to other organelles, and secretion of lipids to the extracellular environment by specialized cells such as hepatocytes, intestinal epithelial cells and macrophages. Lipid biosynthetic capacity must match these export demands in order to maintain ER integrity and the membrane requirements of distal organelles. The extended tubular and planar ER network extends to all regions of the cell where it interfaces at membrane contact sites with the PM, mitochondria and Golgi apparatus for the purpose of lipid transfer, integration of metabolic pathways and calcium homeostasis. In this context, it is increasingly apparent that phospholipid synthesis in the ER is spatially integrated with the structure and function of other organelles, which in turn can be negatively impacted by disturbances in ER function. The enzymology and regulation of ER-associated phospholipid biosynthetic pathways have been reviewed in detail [1] [2] [3] . Thus we will focus on the impact of phospholipid biosynthesis on ER membrane organization and expansion, sterol and triacylglycerol (TAG) synthesis and deposition, and organelle interactions. This review will emphasize the importance of phosphatidylcholine (PC) owing to the preponderance of information on its role in ER structure, function and pathologies.
PC synthesis and ER function

PC biosynthesis and regulation
Phosphatidylcholine (PC) is the most abundant phospholipid in eukaryotic cell membranes, and its biosynthesis is essential for ER secretion and membrane expansion during the unfolded protein response (UPR). In mammalian cells, two de novo biosynthetic pathways for PC are localized to the ER. The CDP-choline pathway, first described by Eugene Kennedy and co-workers in the 1950s following their seminal discovery of the use of cytosine nucleotides in phospholipid synthesis [4, 5] , is responsible for the majority of de novo PC production in tissues. In contrast, phosphatidylethanolamine (PE) N-methyltransferase (PEMT) catalyzes the synthesis of PC by successive methylation of the amino headgroup of PE, a reaction that is only quantitatively important in hepatocytes [6, 7] and differentiated adipocytes [8, 9] . PC produced by these pathways is further modified through the Lands cycle by replacement of fatty acids at the sn-2 position by the combined action of the calcium-independent Group VIA phospholipase A2 (iPLA 2 ) and reacylation by lyso-PC acyltransferase [10, 11] .
The CDP-choline pathway consists of three enzyme reactions that convert choline to PC: i) phosphorylation of choline, catalyzed by choline kinase; ii) transfer of CMP from CTP to phosphocholine forming CDP-choline, catalyzed by CTP:phosphocholine cytidylyltransferase (CCT); and iii) transfer of phosphocholine from CDP-choline to diacylglycerol (DAG), catalyzed by CDP-choline (ethanolamine): diacylglycerol choline (choline/ethanolamine) phosphotransferases (CPT and CEPT) [12, 13] (Fig. 1 ). Both choline kinase and CCT are soluble enzymes but the terminal step in the pathway catalyzed by CEPT and CPT occurs in the ER and Golgi apparatus, respectively [14] [15] [16] . CCT is generally considered the rate-limiting and regulated enzyme in the CDP-choline pathway, although evidence of mitogen stimulation [17, 18] and increased expression in cancer cells [19] [20] [21] indicates a regulatory role for choline kinase during cell proliferation. The mammalian PCYT1a and PCYT1b genes encode the CCTα and CCTβ enzymes, respectively. CCTα is ubiquitously expressed, whereas CCTβ 1 , β 2 and β 3 splice variants display restricted tissue distribution [22] [23] [24] . Specific domains in CCTα regulate cell localization and activity: i) a cluster of N-terminal positively charged amino acids followed by an acidic tract constitute a nuclear localization signal [25] ; ii) a catalytic core that is highly conserved among nucleotidyltransferases [26] , iii) a membrane-binding (M) domain that regulates CCTα activity through reversible membrane association [27, 28] ; and iv) a C-terminal phosphorylation (P) domain containing 16 serine phosphorylation sites that modulates enzyme activity by partially interfering with membrane binding [29, 30] .
An important regulatory feature governing PC synthesis is the reversible association of CCTα with membranes in response to lipid activators and/or membrane structure. In the presence of membranes enriched in lipid activators, domain M undergoes a conformational switch from a structure dominated by random coil conformations to an ordered amphipathic α-helix, creating a hydrophobic face for insertion into membranes [31] . Electrostatic interactions at the boundaries of the hydrophobic face also promote membrane binding of CCTα [32] . The inhibition and activating functions of domain M are localized to a conserved 22-amino acid segment that interacts with the catalytic domain and membranes [33] . In the absence of membranes, this segment of the amphipathic helix silences catalytic activity by association with the active site helix αE; association with membranes relieves inhibition, resulting in a~100-fold elevation in PM Fig. 1 . Localization of phospholipid metabolism and transport in the ER and at organelle contact sites. Phospholipid metabolic and transport pathways are specifically located at membrane contacts between the ER and mitochondria (MT), peroxisomes (PEX), plasma membrane (PM) and Golgi apparatus. ER-mitochondria and ER-LD contacts allow for reconstitution of biosynthetic pathways by lipid transport/or membrane fusion between associated organelles. In the case of the PM, Golgi and peroxisomes, ER membrane contacts allow for site-specific delivery of lipid and sterols between organelles independent of bulk vesicular transport mechanism. Differential localization of CCTα contributes to discrete nuclear (NE deformation and nuclear lipid synthesis) versus cytoplasmic (TAG storage and secretion, anterograde secretion) functions. Abbreviations: ceramide transport protein, CERT; cholesterol, Chol; phosphatidylinositol 4-phosphate, PI4P; phosphocholine, PCho; phosphatidylserine synthase I/II, PSS1/2. k cat and a > 10-fold decrease in the K m for CTP [33] [34] [35] . In vitro and in vivo studies have identified two distinct classes of membrane lipid activators of CCT. Class I activators include anionic lipids and fatty acids that interact with positively charged lysine residues near the interfacial region in domain M [27, 36] . In cultured cells, endogenous or exogenous sources of fatty acids promote membrane translocation and activation of CCTα activity [37] [38] [39] . Class II activators, including DAG and unsaturated PE, promote curvature elastic stress in membranes and introduce gaps in the packing of polar head groups within planar bilayers, favoring insertion of the hydrophobic face of the domain M amphipathic helix [40, 41] . Lipids that negatively regulate CCTα membrane binding include lyso-PC [42] , sphingosine [43] and ceramide [44] . Since PC is zwitterionic and forms planar bilayers, its relative abundance reduces lateral packing stress and negative charge leading to reduced membrane association and activity of CCTα. Thus domain M 'senses' the relative membrane abundance of the precursors and product of the CDP-choline pathway, resulting in appropriate changes to CCTα activity and PC homeostasis.
CCTα is nuclear-localized in many cells and tissues [45] , and translocates to the inner nuclear envelope when activated [46] . Nuclear CCTα may serve to coordinate PC synthesis with membrane expansion during the cell cycle [47] or support the synthesis of an endonuclear pool of PC [48] (Fig. 1) . It has been postulated that CCTα shuttles between the nucleus and cytoplasm in response to stimulatory signals, and that CDP-choline for bulk PC synthesis is formed primarily by extranuclear CCTα following its translocation to the ER [49] . In support of this theory, CCTα is cytoplasmic in type II alveolar cells [50] and nuclear/cytoplasmic in hepatocytes [51] , both of which require increased PC biosynthetic capacity for secretion of surfactant and lipoproteins, respectively. On the other hand, the exclusive nuclear localization GFP-tagged CCTα in synchronized cells is independent of cell cycle mediated fluctuations in PC biosynthesis [52] . This suggests that the CDP-choline produced by nuclear CCTα is available to CEPT in the ER for conversion to PC or the steadystate nuclear distribution of CCTα reflects a rapid export/import cycle that facilitates the synthesis of CDP-choline at the ER.
Intersection of phospholipid and TAG biosynthesis
The synthesis of PC and TAG, required for the assembly of cellular lipid storage droplets and lipoproteins, utilizes DAG that is made de novo from phosphatidic acid (PA) synthesized by a three-step pathway involving mitochondrial-, ER-and nuclear-localized enzymes.
Results from animal and cell culture experiments indicate that the rate of DAG and PA biosynthesis, and the activity of TAG and Kennedy pathway enzymes, influence the synthesis and fatty acid composition of TAG, PC and PE. The initial step in the synthesis of PA is catalyzed by a family of glycerol 3-phosphate acyltransferases (GPAT) that localize to the ER and outer mitochondrial membrane. Cell culture and in vivo knockout mouse models show that TAG biosynthesis is regulated by the localization and activity of GPAT isoforms. The expression of GPAT1 in the outer mitochondrial membrane is strongly induced by insulin signaling via SREBP1c [53, 54] and has a primary function in channeling acyl-CoA into TAG in lipogenic tissues [55] . While PL synthesis in Gpat1 −/− mice was unchanged, there was a significant reduction in the palmitate content of hepatic and cardiac PC and PE, consistent with the substrate specificity of the enzyme [56, 57] . The acyl-CoA-dependent acylation of lyso-PA to form PA is catalyzed by acylglycerolphosphate acyltransferase (AGPAT) 1-5, polytopic integral membrane proteins of the ER with distinct tissue expression profiles. AGPATs reportedly influence lipogenesis in adipocytes and liver (reviewed in [58] ) but their roles in phospholipid synthesis are unknown. These data suggest that the redundancy and capacity in the PA biosynthetic is necessary for channeling fatty acids into TAG but has minimal influence on bulk PL synthesis.
PA is the precursor for synthesis of CDP-DAG, cardiolipin and phosphatidylinositol, or is dephosphorylated to DAG for synthesis of PC and PE by the CDP-choline/ethanolamine (Kennedy) pathways and acylation to TAG. The dephosphorylation of PA, a pivotal step in de novo biosynthesis of glycerolipids, is catalyzed by a magnesiumdependent PA phosphatase (PAP). S. cerevisiae PAP is encoded by pah1 [59] and shares homology with mammalian LIPIN that was originally identified in a spontaneous mutant mouse (fld) that exhibited fatty liver dystrophy and severe lipodystrophy [60] . Pah1p activity is regulated by phosphorylation and reversible association with the ER and nuclear envelope via an extended amphipathic helix [61] . Multisite phosphorylation of Pah1p by Pho85p-Pho80p reduces catalytic activity and association with membranes, while the Nem1p-Spo7p phosphatase complex dephosphorylates and activates the enzyme [62] [63] [64] . Studies using yeast deletion stains indicate that Pah1p regulates inositol-dependent lipid synthesis via the PA-dependent Opi1p/Ino2p/Ino4p transcriptional complex, as well as controlling the balance between PA and DAG utilization by the CDP-DAG and Kennedy pathways. Deletion of pah1 results in reduced PC and TAG mass, but the ER and nuclear envelope membranes proliferate, partially due to derepression of lipid synthesis via the CDP-DAG pathway [61, 63, 65] .
In mammalian cells, LIPIN-1, -2 and -3 regulate TAG and fatty acid homeostasis in white and brown adipocytes, liver and skeletal muscle but have a minor effect on the partitioning of PA or DAG into phospholipid biosynthetic pathways. mTOR dependent phosphorylation of LIPIN-1 was shown to prevent nuclear import where it represses SREBP1c transcriptional activity and expression of lipogenic genes [66] . Nuclear distribution of hepatic LIPIN-1 is also necessary for activation of fatty acid oxidation pathways via interaction with PPARα and the PPARγ co-activator PGC-1α [67] . These transcriptional circuits are primarily involved in fatty acid homeostasis and do not directly influence the expression of phospholipid biosynthetic genes. Consistent with the lack of effect of LIPIN activity on phospholipid biosynthesis, Lipin-2 knockout mice have increased cerebellar accumulation of PA but other phospholipids are unaffected [68] . In McA-RH7777 hepatoma cells, ectopic expression or silencing of LIPIN-1 enhances or suppresses, respectively, TAG, PC and PE synthesis and secretion [69] . In contrast, the synthesis and secretion of TAG from 14-day LIPIN-1 deficient fld mouse hepatocytes is increased, an effect that is suppressed by adenovirus expression of LIPIN-1 [70] .
Collectively, these studies have defined essential roles for GPAT-1 and LIPIN in TAG synthesis, but scant evidence, except in yeast, that this is coupled to changes in phospholipid synthesis. Rather, the availability of de novo synthesized PA or DAG is correlated with TAG synthesis, either through substrate availability or the mTORC2 nutrientsignaling pathway [71] . However, it should be noted that blocking the flux of DAG into phospholipid or TAG by manipulating the activity of downstream enzymes causes a significant diversion of substrate and biosynthetic activity. For instance, diacylglycerol acyltransferase (DGAT)1 overexpression [72] or knockout of both Dgat genes in MEFs [73] results in decreased or increased Kennedy pathway activity, respectively. Blocking the PE and PC Kennedy pathways by liverspecific knockout of CTP:phosphoethanolamine cytidylyltransferase [74, 75] or CCTα [76] , respectively, significantly increased TAG synthesis as the result of substrate diversion and/or reduced TAG secretion.
Cell culture experiments have also demonstrated diversion of DAG into TAG when the CDP-choline pathway is compromised [77] , suggesting a common pool of DAG is available to DGAT and CEPT/CPT.
Role of PC in very low density lipoprotein secretion
Excess fatty acid and cholesterol is esterified to form TAG and cholesterol ester, respectively, seeding the formation of cytosolic lipid storage droplets or, in the case of hepatocytes, very low-density lipoproteins (VLDL). This allows energy storage and export, and also maintains membrane integrity by reducing cholesterol and fatty acid accumulation [78] . The genesis of VLDL is highly dependent on the concomitant synthesis of PC, which along with PE forms a surrounding phospholipid monolayer. Mouse knockout models of hepatic ER phospholipid metabolism have illuminated roles for specific PC biosynthetic pathways in lipoprotein secretion [79, 80] . Approximately 70% of hepatic PC synthesis is via the CDP-choline pathway with the remainder synthesized via PE methylation. In mice, disruption of Pcyt1a is lethal at embryonic day 3.5 [81] , whereas liver-specific deletion has no affect on viability despite a 25% decrease in hepatic PC mass [82] . CCTα-deficient murine hepatocytes have defective assembly and secretion of VLDL, and efflux of cholesterol and phospholipid to high-density lipoprotein, leading to accumulation of large LDs [83] . Pemt −/− mice display severe liver pathology when fed a cholinedeficient diet, suggesting that PE methylation is essential when dietary choline availability is low, such as during starvation [84] . Despite an adaptive increase in hepatic CCT activity and no overall change in hepatic PC mass, male Pemt −/− mice fed a high-fat/high-cholesterol diet are deficient in the packaging and secretion of VLDL. Thus PEMT-derived PC plays an important role in VLDL assembly in hepatocytes that cannot be compensated by the CDP-choline pathway. The mechanism for this could involve the localization of PEMT to mitochondrial-associated membranes (MAM), an ER-domain that is in contact with mitochondria (see Section 4.1, Fig. 1 ). ER-mitochondrial contact zones could facilitate the concerted synthesis and channeling of phosphatidylserine (PS)-derived PC into lipoprotein assembly. Alternatively, the methylation of PE could maintain optimal PC/PE ratios required for ER and Golgi secretion [85] . Increased content of the non-bilayer lipid PE would increase negative membrane curvature and affect the activity of curvature-sensitive proteins. For instance, lipid packing and membrane curvature regulate ARF-GAP activity and COPI-mediated transport [86] .
Role of PC in intracellular triglyceride storage
Despite substrate partitioning between the glycerolipid pathways described in Section 2.2, TAG deposition in LDs is coordinated with the synthesis of PC at the level of CCT and PEMT regulation. A role for CCT activity in regulation of LD size has been identified in D. melanogaster S2 cells [87] . Although the CCTα ortholog CCT1 is nuclear-localized in insect cells at steady-state, fluorescence loss in photobleaching experiments showed that CCT1 rapidly shuttles between the nucleus and cytoplasm under basal conditions, and localizes almost exclusively to the surface of LDs via its amphipathic α-helix upon oleate-loading and LD expansion [87] . LD localization of CCT1 was delayed following oleate treatment, suggesting a dynamic process whereby nuclear/cytoplasmic shuttling allows CCT1 to monitor the PC content on lipid droplets, translocating to the lipid droplet surface to stimulate CDP-choline synthesis when PC content is limiting. CCTα is also associated with LDs in oleate-treated mouse macrophages [87] and proteomic studies have identified CCTα on isolated lipid droplets from differentiated Caco-2/TC7 enterocytes [88] . Consistent with the reduced ratio of phospholipid/TAG as LD volume increases, LD size is increased in hepatocytes and macrophages from tissue-specific CCTα knockout mice [83] , and in S2 cells in which other key phospholipid biosynthetic enzymes are knocked down [87] . Increased LD size could result from fusion of small LDs promoted by decreased levels of PC in the surrounding phospholipid monolayer, which acts as a surfactant to prevent lipid droplet coalescence [87] . Increased TAG synthesis due to shunting of DAG away from phospholipid synthesis could also contribute to increased LD size in CCT-deficient cells [89] .
It is unknown how CCT activity and CDP-choline formation on the LD surface leads to changes in the PC content of LDs since the terminal reaction in the Kennedy pathway is catalyzed by the ER/Golgi enzymes CEPT and CPT. CEPT protein and activity are not associated with isolated LDs from A431 cells [88, 90] , but CDP-choline produced by CCTα on LDs could stimulate PC synthesis in adjacent ER membranes (Fig. 1) . The incorporation of PC into LDs could involve phospholipid transfer proteins, perhaps facilitated by the close apposition of LDs with ER membranes [91] [92] [93] [94] . Alternatively, PC may be incorporated by lateral diffusion through membrane junctions or "bridges" joining the ER and LDs, as proposed in a model of LD biogenesis [95] and visualized by EM [96, 97] .
Concurrent with a decrease in the cellular PC/PE ratio, PEMT expression is induced upon differentiation of mouse 3T3-L1 fibroblasts into adipocytes [8] . Similarly, PEMT expression is induced in the adipocytes of mice fed a high-fat diet, and adipocyte hypertrophy is observed in Pemt −/− mice. Even though PEMT is an integral membrane protein, it co-localizes to the outer monolayer of LDs in differentiated 3T3-L1 cells [8] . While the mechanism of PEMT association with lipid droplets is unclear, it was recently demonstrated that GPAT4, an integral membrane protein, that catalyzes the first step in de novo TAG synthesis, localizes to LDs in response to oleate treatment in S2 cells [97] . Topology determinations showed that GPAT4 has two transmembrane domains that are unusually long for ER-spanning α-helices suggesting that it may adopt a more favorable hydrophobic hairpin structure within the phospholipid monolayer and underlying hydrophobic core of the LD. Strikingly, GPAT4 was only localized to a subset of LDs containing CCT1 that expanded in size upon oleate treatment and not to a static population of LDs [97] . Enzymes involved in the Lands cycle, such as lyso-PC acyltransferase-1 and − 2, and calcium-independent and -dependent PLA 2 , also affect LD size and metabolism of core lipids, further supporting the essential role of PC in regulating TAG storage [90, 98, 99] .
Regulation of ER cholesterol homeostasis by PC
Because of their opposing effects on membrane fluidity [100] , PC and cholesterol are maintained within narrow limits by metabolic co-regulation [101] . The central mediators of membrane homeostasis are the sterol regulatory-element binding proteins (SREBPs), which regulate expression of a gene network involved in cholesterol and fatty acid synthesis, and lipoprotein uptake. Three SREBP isoforms in mammalian cells have separable but overlapping gene targets; SREBP-1a activates both cholesterol and fatty acid synthesis, while SREBP-1c and SREBP-2 are relatively specific for fatty acid and cholesterol synthesis, respectively [102] . SREBPs are synthesized as inactive, membrane-bound precursors localized in the ER. Vesicle-mediated transport to the Golgi apparatus in response reduced cholesterol levels results in the cleavage of SREBP by Golgi-resident proteases, releasing a mature transcription factor that transports to the nucleus to activate target genes [103] . The cholesterol 'sensor' is the transmembrane SREBP cleavage-activating protein (SCAP) that escorts SREBPs from the ER to the Golgi apparatus, and INSIGS, which bind oxysterols. Cholesterol binds directly to SCAP, resulting in a conformation that favors binding to the ER-resident protein INSIG, which in turn inhibits recruitment of the SCAP/SREBP complex into COPII vesicles at ER exit sites [104] . In CHO cells, SREBP-2 processing is inhibited when ER cholesterol levels reach a threshold of 5 mol% of total ER lipids [105] . This threshold was lowered to 3 mol% in cells overexpressing INSIG-1. Thus processing of SREBPs is ultimately regulated by the cholesterol/phospholipid ratio of the ER, which is relatively low compared to other organelles and sensitive to small fluctuations in cholesterol mass [105] .
While this model elegantly explains negative feedback control of cholesterol biosynthesis in response to cellular demands for membrane cholesterol, it remains to be established how the SREBP pathway integrates phospholipid and TAG metabolism to maintain overall membrane homeostasis, and how this balance is perturbed in pathological states. Importantly, in vivo studies show that SREBP-2 and SREBP-1c are not coordinately regulated in hamster liver; sterol depletion leads to an increase in the mature nuclear form of SREBP-2 but a decline in the nuclear form of SREBP-1c [106] . Both transcription factors are down-regulated in mice during fasting; however, SREBP-1c levels increase 4-to 5-fold above non-fasted levels upon high-fat/high carbohydrate feeding, whereas SREBP-2 levels only return to non-fasted levels [107] . Thus SREBP-1c is highly regulated by nutritional status compared to SREBP-2.
Since phospholipid synthesis requires a supply of fatty acids, the differential processing of SREBP isoforms in mammalian cells could be critical for the maintenance of phospholipid synthesis when cellular cholesterol levels are elevated or in other situations where phospholipid demand is increased. SREBP-1 does not transcriptionally activate PC biosynthetic genes but stimulates PC synthesis by increasing production of pathway substrates and/or activators of CCTα [39, 108] . Several studies have also shown that phospholipid metabolism can regulate the processing SREBP-1 orthologs in Drosophila melanogaster [109, 110] and Caenorhabditis elegans [111] by a negative feedback mechanism. The latter study also showed that this mechanism is conserved in mammalian cells. In HepG2 cells, siRNA-mediated knockdown of CCTα or CEPT resulted in nuclear accumulation of SREBP-1 and increased expression of target genes [111] . Decreasing PC synthesis did not affect SREBP-2 processing, and the effect on SREBP-1 processing was independent of cholesterol. Similarly, in liver-specific CCTα knockout mice, hepatic nuclear SREBP-1c levels were increased relative to wild-type controls, whereas nuclear SREBP-2 levels did not change. CCTα silencing in HepG2 cells resulted in re-localization of Site-1 and Site-2 proteases from the Golgi apparatus to the ER. These findings led to speculation that lowering the PC/PE ratio in ER membranes activates ARF-GAP by altering membrane curvature, resulting in inhibition of anterograde transport and constitutive processing of SREBP-1 in the ER. In support of this theory, the ARF-GEF inhibitor brefeldin A causes transportindependent processing of SREBP-2 by relocalizing Site-1 proteases from the Golgi to the ER [112] . While ER retention of Site-1 and Site-2 proteases explains the role of PC metabolism in SREBP-1c processing, it is unclear why SREBP-2 processing was not similarly effected by changes in PC synthesis.
Role of PC metabolism in ER-stress pathways
Effect of PC depletion on ER-stress.
Inhibition of PC synthesis leads to the induction of a regulatory program triggered by ER-stress termed the unfolded protein response (UPR), which is comprised of three signaling pathways involving the ER transmembrane sensors IRE1 (inositol requiring enzyme 1), PERK (double strand RNA-activated protein kinase-like eukaryotic initiation factor 2a kinase) and ATF6 (activating transcription factor-6). When the ER is stressed by accumulation of misfolded proteins or perturbations in lipid homeostasis, the UPR functions to reduce protein synthesis, increase protein degradation, expand ER membranes and enhance protein folding. If these responses fail to reestablish ER homeostasis, the UPR can trigger apoptotic cell death through PERK-mediated activation of the pro-apoptotic factor C/EBP homologous protein (CHOP). An unambiguous role for PC synthesis in apoptotic cell death associated with the UPR occurs in MT58 cells, Chinese hamster ovary cells that express a temperature-sensitive CCTα allele [113] [114] [115] . Incubation of MT58 cells at the non-permissive temperature of 40°C results in depletion of PC by 24 h and activation of CHOP at 48 h [114] . MT58 cells are rescued by supplementation of the medium with PC or lyso-PC, which can be utilized by the Lands pathway [115] , indicating that alternate sources of PC can bypass a requirement for the CDP-choline pathway. Depletion of PC in MT58 cells results in dilation and reorganization of rough ER, and accumulation of large lipid droplets [116] . Surprisingly, PC depletion does not affect protein transport from the ER, but inhibits protein transport in the Golgi apparatus, indicating increased sensitivity of the Golgi apparatus to inhibition of PC synthesis [116] .
Role of PC in cholesterol-induced ER-stress.
When storage of cholesterol ester in LDs is compromised, ER cholesterol levels increase and negatively affect protein function leading to ER-stress. Under these conditions, PC synthesis is increased to buffer the cell against elevated membrane cholesterol and prevent toxicity [39, 117] . The induction of PC synthesis plays an important protective role within the arterial wall, where internalization of oxidativelymodified low-density lipoproteins by macrophages and smooth muscle cells leads cholesterol accumulation and plaque formation. Under these conditions, CCTα activity and PC synthesis are increased resulting in the production of membrane whorls that act as 'sinks' to absorb the excess cholesterol [117, 118] . Treatment of cholesterol-loaded macrophages with a protein phosphatase inhibitor blunts the increase in PC synthesis, implicating a mechanism involving increased membrane binding and activity of dephosphorylated CCTα [118] . Since cholesterol is a poor activator of CCTα in vitro, other metabolites that induce CCT activity, such as fatty acids and oxysterols [119] , may activate PC synthesis in cells taking up oxidized lipoproteins. If PC synthesis fails to keep pace with cholesterol accumulation in the ER, the sarco/endoplasmic reticulum calcium-ATPase (SERCA) is inhibited, leading to depletion of luminal ER calcium stores and induction of the CHOP pro-apoptotic arm of the UPR [120] . Importantly, the CCTα-mediated stress response to cholesterol-loading protects macrophages from necrotic cell death [121] . The difference in death responses to cholesterol toxicity (latestage apoptosis versus early-stage necrosis) in macrophage foam cells may play a critical role in atherosclerotic plaque stability by protecting against premature plaque rupture and thrombosis [122, 123] .
Regulation of the CDP-choline pathway during ER proliferation
IRE1-mediated intron splicing of X-box binding proten-1 (XBP-1) mRNA leads to expression of a functional transcription factor and induction of ER chaperones. Ectopic expression of spliced XBP-1 promotes ER proliferation, increased expression and activity of CCTα and CPT/CEPT activity, and increased PC and PE mass [124, 125] . A well-characterized example of ER-stress occurs in immature B-cells upon differentiation into antibody-secreting plasma cells. The increased protein load in the early secretory pathway of these cells leads to proliferation of ER membranes that is in part fueled by membrane translocation and activation of CCTα and PC synthesis controlled by XBP-1 [125] [126] [127] . PC synthesis is also increased independently of XBP-1 by the ATF6 signaling arm of the UPR in response to increased ER-membrane protein levels [128] . As with other mechanisms of ER expansion in response to increased protein load, there is an 'overshoot' in PC production [128, 129] that is balanced by increased PC degradation by calcium-independent PLA 2 [130] . Similar to SREBPs, ATF6 activation is regulated by ER-to-Golgi trafficking and proteolysis by Site-1 and Site-2 proteases [131] . Therefore, it is conceivable that ATF6 signaling could be mechanistically linked to increased SREBP-1c processing in a coordinated response to increased cellular demand for fatty acids and phospholipids during membrane expansion.
PC in palmitate-induced ER-stress
In addition to regulating cholesterol and fatty acid synthesis, SREBPs also regulate the unsaturation of fatty acids by transcription of stearoyl-CoA desaturase-1 (SCD1). SCD1 is expressed in the ER where it catalyzes the Δ9-desaturation of palmitate (16:0) and stearate (18:0) to palmitoleate (16:1n− 9) and oleate (18:1n− 9), respectively. Unsaturated fatty acids activate the synthesis of TAG by DGAT for incorporation and storage in LDs. In contrast, excess saturates are poorly incorporated into TAG and accumulate in other lipids or are oxidized [78, 132] . Scd1 −/− mice are resistant to high-fat/high carbohydrate diet-induced weight gain and liver steatosis as a result of decreased fatty acid synthesis and increased β-oxidation [133, 134] . In the livers of Scd1 −/− mice, CCT and CPT activities are elevated and PC content is increased 40% [135] . Conversely, expression of PEMT is decreased by 80%, indicating a shift towards PC synthesis via the CDP-choline pathway [135] . Increased CDP-choline pathway activity could sequester excess saturated fatty acids in PC and prevent accumulation in other potentially toxic lipids such as DAG and ceramide. However, this protective mechanism may fail when saturated fatty acids reach a critical level. Palmitate administered to CHO cells or cardiomyoblasts is rapidly incorporated into ER phospholipids leading to impaired ER structure and integrity [136] . In HeLa cells, SCD1 knockdown decreased unsaturated fatty acids in phospholipid, and induced the UPR and eventually apoptotic cell death [137] . Lyso-PC acyltransferase 3, which preferentially incorporates polyunsaturated fatty acids into PC via the Lands pathway, is up-regulated in SCD1 knockdown cells. Knockdown of lyso-PC acyltransferase-3 and SCD1 synergistically enhanced palmitate-induced UPR [137] , suggesting that a decrease in membrane phospholipid unsaturation causes ER stress.
It is well established in rodent models that obesity induces ER-stress and UPR in multiple tissues [138] [139] [140] . In obese mice, compromised UPR signaling increases insulin resistance [138] , whereas measures to reduce ER stress improve insulin signaling and glucose tolerance [141, 142] . ER-stress markers are also increased in adipose tissue of obese humans [143] , and treatment with the chemical chaperone sodium phenylbutyrate, a drug that reduces ER stress, partially alleviates insulin resistance and pancreatic β-cell dysfunction in obese non-diabetic subjects [144] . A recent proteomic and lipidomic analysis of the ER isolated from the livers of obese leptin-deficient (Lep −/− ) mice revealed an increase in the PC/PE ratio and mono-unsaturated fatty acid content of phospholipids compared to non-obese controls [145] . These findings were correlated with decreased SERCA activity in microsomes from obese mouse livers. Importantly, silencing of PEMT activity normalized the PC/PE ratio in obese mice, increased SERCA activity and decreased markers of ER stress. Suppression of PEMT also improved glucose tolerance in Lep −/− mice, an observation that is consistent with earlier studies showing that Pemt −/− mice are protected from diet-induced obesity and insulin resistance [146] . It is apparent from these results that increased food intake stimulates synthesis of PC, consistent with its essential role in the packaging of excess lipid in LDs and lipoproteins. Eventually a distorted PC/PE ratio in ER membranes negatively impacts calcium homeostasis and ER stress ensues. A future challenge will be to translate these findings into mechanisms for targeting phospholipid metabolism in chronic diseases of ER dysfunction, such as obesity and diabetes.
Coordination of phospholipid synthesis at ER-organelle contact zones
ER-mitochondrial contacts
The extended ER network forms stable or quasi-stable interactions with other organelles when the spacing between opposing membranes is b30 nm, the predicted distance spanned by a tethering protein complex(es) [147, 148] . Sites of membrane contact identified by microscopic and biochemical techniques include the Golgi apparatus [149] , mitochondria [150, 151] , plasma membrane [152] and endosomes [153] . A distinct ER domain termed the MAM forms dynamic contacts with mitochondria that are hot-spots for lipid metabolism [154] and calcium signaling that controls ER and mitochondrial stress and energetics [155, 156] (Fig. 1) . MAM has features of smooth ER but is reportedly enriched in lipid biosynthetic enzymes, including PEMT and PS synthases [150, 157, 158] , GPAT1 [159] and acyl-CoA synthase 4 [160] . PS synthesized in the MAM by PS synthases I or II is transferred to the inner mammalian mitochondrial membrane by an unknown mechanism where it is converted by PS decarboxylase to PE, which is subsequently exported to the ER and other organelles (Fig. 1) . Reconstitution of this pathway in permeabilized cells or with isolated ER and mitochondrial fractions is ATP-dependent but does not require soluble protein factors [161, 162] . PS synthases I and II are integral membrane proteins that exchange serine for the head group of preexisting PC or PE, respectively [163, 164] . Although the bulk ER has PS biosynthetic activity, the specific activity in MAM is significantly greater [158] . However, enzyme activity profiles did not correlate with expression of endogenous PS synthase I and overexpressed PS synthase II protein, which are almost completely localized to MAM fractions isolated on Percol gradients [158] . This could indicate the presence of another ER-specific PS synthase isoform, or an influence of the ER membrane environment on PS synthase activity.
PEMT activity is found in crude microsomes as well as MAM, however a 20 kDa isoform of the enzyme referred to as PEMT2 that reacted with a carboxyl-terminal-specific antibody was absent from the ER but detected exclusively in MAM [157] . The MAM-specific PEMT is not an alternate promoter transcript since these have identical coding sequences [165, 166] , suggesting a post-transcription modification is involved in targeting it to the membrane contact site. In vitro incubation of MAM and mitochondria with radiolabelled serine and S-adenosylmethionine resulted in isotope incorporation into PC [150, 167] . This suggests a concerted lipid synthesis/transport pathway wherein PS is made in the MAM, transported to PS decarboxylase on the inner mitochondrial membrane for conversion to PE and subsequently transferred to the MAM for methylation by PEMT2 (Fig. 1) . MAM could also contribute to hepatic lipoprotein secretion by concentrating acyl-CoA acyltransferase, DGAT2 and PS metabolic activities at a pre-Golgi site of nascent lipoprotein assembly [168, 169] . Mitochondrial lipid biosynthetic and energetic capacity could then be coordinated with lipoprotein assembly in the ER.
It is unlikely that the lipid biosynthetic enzymes localized to ER/mitochondrial contact sites are sufficient for stable tethering of opposing membranes. However, putative tethering factors, including mitofusins 1 and 2 [151] and a voltage-dependent ion channel (VDAC)/IP3R/ GRP75 complex [148, 170] , have not been implicated in providing stable contacts for lipid transport. In yeast, ER/mitochondrial contacts are dependent on an ER-mitochondrial encounter structure (ERMES) composed of four proteins; Mdm10, Mdm34, Mmm1 and Mdm12 that do not have apparent mammalian homologues [171] . The ERMES complex has a primary role in maintaining structural morphology of the mitochondria but does not directly participate in PS transport or conversion to PE [148] . However, ERMES may interact with other ER shaping reticulons to enhance PS decarboxylation in the mitochondria [172] .
Perturbations in lipid metabolism at the MAM are linked to Alzheimer disease [173, 174] . Presenilin 1 and presenilin 2, components of the γ-secretase complex that processes β-secretase-cleaved APP into the Aβ40 and Aβ42 amyloidogenic fragments, are enriched in the MAM based on co-fractionation with specific markers [173, 175] . In these and other studies [176, 177] , MAM isolated from different tissues contained detergent-resistant membranes (DRM), and are enriched in cholesterol, ceramide and sphingolipid relative to bulk ER [173, 176] . These findings are consistent with the preferential association of presenilins with DRMs [178] . Fibroblasts from Alzheimer patients and presenilin-null fibroblasts have increased [ 3 H]serine incorporation into PS and PE, increased cholesterol esterification, and more contact zones between the ER and mitochondria [173] . This suggests that presenilin 1/2 expression is negatively correlated with increased MAM-associated lipid metabolism, indicating these proteins are negative regulators of MAM function, and that Alzheimer disease could be a consequence of altered MAM activity that affects other downstream amyloidogenic pathways.
Lipid metabolism at other ER-organelle contact zones
ER contacts with other organelles have been identified at the microscopic level but, unlike the mitochondria and PM, the isolation of contacting membranes and the structural components involved have not been achieved. Electron tomography has revealed contacts between the ER and trans-Golgi cisternae that could mediate lipid and cholesterol transport between these compartments [149, 179] . Oxysterol binding protein coordinates the formation of a sterol-dependent lipid transport complex that contains ceramide transfer protein [180] , the PI/PC-transfer protein Nir2 and VAMP-associated protein, a type II ER protein [181] (Fig. 1) . The recruitment of these lipid transfer proteins regulates the levels of DAG, sphingomyelin and phosphatidylinositol 4-phosphate in the Golgi apparatus and secretory events that dependent on these lipids. ER-Golgi contacts formed by these proteins have not been identified by microscopic techniques nor are they amenable to isolation, suggesting the involvement of weak protein-lipid interactions.
Although peroxisomes likely derive their membrane lipids during biogenesis from the ER [182, 183] , there is also rapid delivery of PS to peroxisomes in vitro that is stimulated by ATP and soluble transport proteins [184] (Fig. 1) . The transfer of PS to peroxisomes in yeast is similar to ER-mitochondrial transport but it is unknown if stable membrane contacts are involved or whether other lipids are transported to peroxisomes in a similar manner.
Yeast and mammalian cells have clearly identified contacts between the tubular ER and PM that are important communication junctions with the external environment. In mammalian cells, the luminal ER calcium sensor stromal interaction molecule-1 (STIM-1) interacts with Orai, the pore forming subunit of the store-operated calcium channel, leading to increased calcium entry in response to ER calcium depletion [185] . STIM-1-regulated calcium entry regulates a variety of downstream signaling pathways involved in cell proliferation, differentiation and apoptosis (reviewed in [186] ). Yeast contain extensive contacts between the PM and underlying cortical ER that involve the ER-resident proteins Tcb1p1/2/3, Ist1p, Scs2p and Scs21p [187] . PM-cortical ER contacts are also sites for PI 4-phosphate metabolism and sterol trafficking/ signaling mediated by Sac1p and oxysterol binding proteins, respectively [188, 189] (Fig. 1) . The importance of these contacts to ER function is illustrated in deletion stains, which have collapsed cortical ER and accumulation of cytoplasmic membrane tubules and sheets, accumulation of PI 4-phosphate and induction of the UPR [187] .
Regulation of ER architecture by phospholipid metabolism
Membrane deformation by lipid metabolic enzymes
The ER is organized into several functional domains; a nuclear envelope perforated with nuclear pore complexes, perinuclear planar arrays of membrane sheets studded with ribosomes, COPII export pathways that emanate from transitional ER and a branched, tubular network that extends to the cell periphery. The complex membrane landscape of organelles such as the ER is dictated by 1) the relative content of phospholipids with intrinsic curvature properties and 2) association of modifying proteins that that change the curvature of membranes by direct interaction [190, 191] . While there are examples of membrane curvature induction involving both lipids and modifying proteins [191] , the localized asymmetric distribution of lipids has not been implicated in generation of ER membrane heterogeneity [192] . Rather, the complex spatial organization of the ER depends on membrane-deforming proteins and interaction with the cytoskeletal network [193] . Positive membrane curvature evident in tubular ER and at the ends of planar sheets is the result of ER-shaping reticulons and DP1/YOP1 proteins that are sufficient to maintain tubular ER in cells and which generate lipid tubes in vitro by oligomerization and asymmetric bilayer insertion.
As summarized in a recent review [3] , many ER-localized enzymes are polytopic, integral membrane proteins that could theoretically form a hydrophobic 'wedge' and induce membrane curvature in a manner similar to reticulons. Coupled with this, enzyme activity could augment or counter membrane curvature depending on the physical properties of the lipid substrate(s) and product(s). Other lipid biosynthetic enzymes are amphitropic in nature and reversibly interact with membranes by amphipathic helices or other mechanisms, potentially effecting membrane curvature in response to the lipid environment. Alternatively, helices could bind to membranes in response to intrinsic curvature, so called curvature-sensing domains [86, 194] . While there are no examples of integral membrane enzymes that affect ER architecture, several amphitropic lipid metabolic enzymes have been implicated in curvature induction of biological membranes in vitro and in cultured cells. The rate-limiting enzyme in the CDP-choline branch of the Kennedy pathway, CCTα see Section 2.1), is involved in formation of membrane invaginations of the inner and outer nuclear envelope that comprise a tubular (100-500 nm diameter), branching nucleoplasmic reticulum (NR) [195, 196] (Fig. 1) . NR invaginations, which are ubiquitously observed in cultured cells and tissues [197] , are extensions of the ER and cytoplasm that bring nuclear pore complexes deep within the nucleoplasm and thus may facilitate nucleo-cytoplasmic transport and communication [198] . Formation of the NR in cultured cells is stimulated by CCTα expression and activation by oleate, and requires domain M. Amino acid substitutions in domain M that enhance membrane binding cause the formation of stacks of intranuclear lipid tubules (25 nm diameter) that contain CCTα [196] . NR formation by CCTα also requires lamins [196, 199] , suggesting that he nuclear lamina provides a framework that supports invagination of the NE. Incubation of recombinant CCTα with liposomes of heterogeneous composition also caused the formation of 50 nm tubules [195] . Tubulation of liposomes composed of PC/PG was highly efficient compared to heterogeneous lipid mixtures, resulting in uniform non-branching tubules of 12 nm diameter estimated to have 50 molecules of phospholipid per mole of CCTα [199] . Under the same conditions, domain M peptides were sufficient to tubulate liposomes. Based on the distribution and the extent of tubule formation at differing CCTα concentrations, it was proposed that CCTα could also sense and preferentially bind membranes with positive curvature [199] . This suggests that CCTα alters the structure of the nuclear envelope, inducing invaginations that are dependent on lipid composition and nuclear lamins. Membranemodifying functions are likely not restricted to the inner NE since CCTα is exported to the cytoplasm in response to cell proliferation and enzyme activation where it could remodel the tubular and planar ER network depending on localized lipid composition and intrinsic curvature. Thus CCTα translocation to membranes in response to changes in lipid composition adjusts flux through the CDP-choline pathway and integrates this with localized membrane remodeling.
Calcium-dependent cPLA2α catalyzes the release of arachidonate from the sn-2 position of PC upon calcium binding by its C2 domain and translocation to membranes. [200] . cPLA2α interacts with the perinucler ER, NE and Golgi apparatus depending on the concentration and duration of calcium transients [201] . Translocation of cPLA2α is essential for the enzyme to access its substrate but the C2 domain is also capable of inducing membrane curvature. The formation of intra-cisternal Golgi tubules is dependent on cPLA2α translocation and enzyme activity [202, 203] . On the other hand, Fc-receptordependent phagocytosis required cPLA2α but enzyme activity was dispensable and the isolated C2 domain was sufficient to reconstitute phagocytosis [203] . The calcium-dependent tubulation of giant PC liposomes by the C2 domain was sensitive to mutation of key hydrophobic residues that mediate membrane insertion [204] . This suggests a model wherein the cPLA2α C2 domain penetrates one leaflet of the bilayer and, if the leaflets remain strongly coupled, an area discontinuity results in positive membrane curvature. Production of lyso-lipids by cPLA2α could enhance positive curvature by virtue of their intrinsic wedge-shape [203] .
The amphipathic helix of LIPIN/Pah1p is required for association with the nuclear envelope [61] and alteration of nuclear shape [66] . Amphipathic helices with a weakly charged polar face enriched in serine and threonine residues preferentially associate with positively curved membranes characterized by loosely packed lipid head groups [205] . The amphipathic helix in Pah1p fits the criteria for this type of lipid-packing sensor. However, Pah1p appears to associate with planar membranes (ER and NE) and not the tubular ER network in yeast. Mammalian LIPIN-1 has a similar N-terminal amphipathic helix that has not been implicated in membrane binding. However, similar to Pah1p, LIPIN-1 also regulates nuclear membrane structure by a mechanism that does not involve direct membrane interaction. Dephosphorylation and nuclear import of LIPIN-1 increased the elipticity of the nucleus, which coincides with suppression of SREBP activity [66] . Recent independent identification of LIPIN-1 as a factor in NE breakdown during mitosis implicates the production of DAG as a catalyst in PKC phosphorylation of lamin B and disassembly of the nuclear lamina [206] . In this scenario, DAG synthesis by LIPIN-1 at the inner NE controls the phosphorylation status of nuclear lamins, contributing to subtle shape changes that could affect gene expression or complete lamin disassembly during mitosis. While many proteins have been identified that contain membrane curvature inducing domains, CCTα, PLA2α and LIPIN-1 are unique in their capacity to also enzymatically modify membrane phospholipid composition.
Tubular ER dynamics and phospholipid synthesis
In mammalian cells, phosphatidylinositol, phosphatidylglycerol and cardiolipin are synthesized from CDP-DAG made by CDP-DAG synthase (CDS) 1 and 2 [207] [208] [209] . CDS1 has several putative transmembrane domains and the overexpressed epitope-tagged enzyme is uniformly localized to the tubule ER and nuclear envelope [210] . Overexpression studies in cultured cells indicate that CDS is not limiting for phosphatidylinositol synthesis [207] . Rather, the rate-limiting enzyme is phosphatidylinositol synthase (PIS), which is encoded by a single ubiquitously expressed gene [207] . GFP-tagged PIS localizes to the tubular ER network with CDS but is also present in an unusual, high-mobility membrane/vesicular compartment that emanates from the ER by a Sar1-dependent mechanism and fleetingly contacts PM-ER junctions that mediate store operated calcium entry [211] . Based on density gradient fractionation, the mobile vesicle fraction has greater PIS activity compared to the bulk ER and only accommodates catalytically active enzyme. Interestingly, CDS1 and 2 are excluded from this fraction indicating that CDP-DAG packaged into vesicles at the ER is sufficient to maintain the synthesis and delivery of PI to other organelles. Recently, similar PIS-enriched domains were identified at the leading edge of dynamic ER tubules that track on microtubules and undergo homotypic fusion [212] . The extension and fusion of these tubules required Rab10; silencing or expression of a GDP-locked form in COS cells resulted in loss of tubular ER and proliferation of a cisternal network. Interestingly, CEPT was also co-localized with PIS and Rab10 indicating that these ER tubules could also require PC synthesis for extension and/or fusion. These dynamic ER structures could be a site for lipid synthesis that, depending on recruitment of GTPases and other factors, extend and fuse or detach to form mobile lipid biosynthetic platforms that deliver lipids to other organelles.
Conclusions
Based on recent studies demonstrating synthesis of phospholipids in specific ER domains, a future challenge will be to understand where phospholipid synthesis and catabolism occur in the ER and how this is integrated with ER-specific functions. The developing theme is that of zones of active lipid metabolism within a vast ER network that are highly dynamic and coordinated with activities occurring in the Golgi apparatus, mitochondria and plasma membrane. Moreover, changes in phospholipid metabolism that occurs in these zones could influence ER function compared to the bulk compartment, including localized changes in phospholipid composition that affect cholesterol synthesis, UPR and organelle contact sites. This ultimately impacts cell physiology and is beginning to be understood at the level of relevant human diseases.
